Back to MDVN Stock Lookup

MDVN Related Analyst Ratings

May 7, 2013 07:38 AM Goldman Sachs Starts Medivation (MDVN) at Buy, Sees 28% Upside

Mar 28, 2013 06:49 AM JMP Securities Starts Medivation (MDVN) at Market Outperform

Mar 4, 2013 08:04 AM Needham & Company Starts Medivation (MDVN) at Buy

Feb 28, 2013 03:47 PM Medivation (MDVN) Reverses after Cowen Research Called into Question by Janney

Jan 2, 2013 05:49 PM Janney Montgomery Scott Starts Medivation (MDVN) at Buy

Dec 19, 2012 01:26 PM UBS Starts Medivation (MDVN) at Neutral

Dec 4, 2012 07:22 AM Barclays Starts Medivation (MDVN) at Equalweight

Dec 3, 2012 11:12 AM Medivation's (MDVN) Xtandi Could See Strong Upside Following PREVAIL - Analyst

Nov 12, 2012 07:23 AM Xtandi Off to a Fast Start (MDVN) - Leerink Swann

Sep 28, 2012 08:55 AM Maxim Group Starts Medivation (MDVN) at Buy

Sep 19, 2012 10:22 AM Wedbush Prostate Cancer Survey Reveals JNJ’s (JNJ) Zytiga has Still-Solid Market Position but Medivation’s (MDVN) Xtandi in Good Position at Launch

Sep 4, 2012 01:55 PM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT on Early Approval

Sep 4, 2012 10:51 AM Leerink Swann Maintains an 'Outperform' on Medivation (MDVN); Number of Advantages Based on Labeling

Sep 4, 2012 08:52 AM Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Adjusting Numbers on Xtandi Approval

Sep 4, 2012 07:17 AM Jefferies Reiterates a 'Buy' on Medivation (MDVN); Xtandi Approved Early

Jul 30, 2012 03:15 PM Maxim Upgrades Dendreon (DNDN) as the Street is 'Too Bearish' Ahead of Q2 Results

Jun 29, 2012 07:16 AM ThinkEquity Starts Medivation (MDVN) at Buy

Jun 19, 2012 09:14 AM Medivation (MDVN) Makes The Best Takeover Target, Not Dendreon (DNDN) - Jefferies

Jun 12, 2012 08:54 AM Aegis Starts SGYP, IRWD, AMRN, MDVN at Buy, PLX at Hold

Jun 4, 2012 09:37 AM Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Zytiga Data Better Than Expected

Jun 4, 2012 09:09 AM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT and 2013 Estimates

Jun 4, 2012 07:40 AM Jefferies Lifts Price Target on Medivation (MDVN) to $105 Following Zytiga Data from ASCO

May 14, 2012 09:07 AM Medivation (MDVN) Shares Indicated Higher as Citi Adds to 'Top Picks Live' List

Apr 25, 2012 09:39 AM Jefferies Predicts Stellar Outlook For Medivation Inc (MDVN) and MDV3100

Apr 12, 2012 09:52 AM Citi Cuts Dendreon (DNDN) Price Target to $10 Amid 'Significant Threats to Provenge'

Mar 22, 2012 09:32 AM Jefferies Maintains a 'Buy' on Medivation (MDVN)); PREVAIL Trial Design Increases Odds of Success

Feb 22, 2012 07:53 AM Citi Assumes Coverage on Medivation (MDVN) at Buy

Feb 6, 2012 08:26 AM Leerink Swann Increases Numbers on Medivation (MDVN) Based on AFFIRM Results and Physician Feedback

Feb 1, 2012 08:50 AM Brean Murray Sees Medivation (MDVN) As a Takeout Target After Strong Data, Sees "Beginning of the End" for Dendreon's (DNDN) Provenge

Feb 1, 2012 07:27 AM Jefferies Raises Medivation (MDVN) Price Target to $95

Jan 31, 2012 08:22 AM Credit Suisse Starts Medivation (MDVN) at Outperform

Nov 3, 2011 01:39 PM Brean Murray Reverses On Medivation (MDVN); Upgrades to Buy and Sees Another 100%+ Upside

Nov 3, 2011 09:16 AM JPMorgan Upgrades Medivation (MDVN) to Overweight

Oct 18, 2011 09:18 AM Summer Street Starts Medivation (MDVN) at Buy

Sep 20, 2011 07:21 AM Jefferies Starts Medivation (MDVN) at Buy

Sep 16, 2011 11:44 AM William Blair Initiates Research Coverage on MDVN, OGXI & DNDN: Three Companies in Prostate Cancer Treatment Space

Sep 16, 2011 09:03 AM William Blair Starts Medivation (MDVN) at Outperform

Sep 8, 2011 08:16 AM Bernstein Starts Medivation (MDVN) at Outperform

Sep 7, 2011 09:35 AM Morgan Joseph Starts Medivation (MDVN) at Buy

Sep 6, 2011 08:28 AM Leerink Swann Upgrades Medivation (MDVN) to Outperform; Positive Outlook for AFFIRM

Aug 10, 2011 03:12 PM Wedbush Assumes Medivation (MDVN) at Outperform, $25 Target

May 10, 2011 07:45 AM Citi Starts Medivation (MDVN) at Buy

May 4, 2011 08:04 AM Global Hunter Securities Reiterates a 'Buy' on Medivation (MDVN); Stock Significantly Undervalued

Apr 29, 2011 11:35 AM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Zytiga (abiraterone) Approved

Apr 12, 2011 07:28 AM Roth Capital Downgrades Medivation (MDVN) to Neutral

Apr 11, 2011 11:53 AM Rodman & Renshaw Cuts Medivation (MDVN) to Market Underperform, Sets $13 Price Target

Feb 16, 2011 08:39 AM Global Hunter Securities Maintains a 'Buy' on Medivation (MDVN); Robust MDV3100 Phase I/II data at ASCO GU

Jan 4, 2011 10:45 AM Global Hunter Securities Reiterates a 'Buy' on Medivation (MDVN); Raising Fair Value Estimate to $19

Nov 30, 2010 09:00 AM Wedbush Assumes Coverage on Medivation (MDVN) at Outperform; An Exciting Time for Prostate Cancer

Jun 29, 2010 03:45 PM Global Hunter Securities Suggest Investors Acquire a Basket of Biotech Stocks

Back to MDVN Stock Lookup